Home/Filings/4/0000899243-21-045918
4//SEC Filing

Zhang Xiaoyan Michelle 4

Accession 0000899243-21-045918

CIK 0001835579other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 9:01 PM ET

Size

5.4 KB

Accession

0000899243-21-045918

Insider Transaction Report

Form 4
Period: 2021-11-22
Zhang Xiaoyan Michelle
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-11-22+176,699176,699 total
    Exercise: $13.75Exp: 2031-11-21Common Stock (176,699 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on November 22, 2022, with the remainder vesting in 36 equal monthly installments thereafter.

Issuer

Ikena Oncology, Inc.

CIK 0001835579

Entity typeother

Related Parties

1
  • filerCIK 0001895321

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 9:01 PM ET
Size
5.4 KB